CryptoCompare
Institutional-grade aggregator covering spot, futures and derivatives across exchanges, with portfolio tracking and a deep public API.
About this site
CryptoCompare is a crypto market-data provider positioned for institutional and developer use, with a public web front-end that is also free to retail. As a subsidiary of Kaiko — a well-known name in digital-asset market data — its product strategy bridges "institutional data backbone" and "end-user products."
The offering breaks into four parts. Market aggregation: spot and derivatives data across thousands of coins and hundreds of venues, with tick-level historical trade downloads available. Indices and benchmarks: published reference rates such as the CryptoCompare Bitcoin Index (CCBI), used by multiple institutional consumers as a pricing reference. Portfolio tools: multi-account aggregation, P&L tracking and tax reporting. REST and WebSocket APIs covering market, reference and on-chain data.
Three audience profiles are served. Developers and quantitative teams use its historical tick and high-frequency data for backtesting. Research analysts cite its indices and exchange benchmark reports as price anchors. Retail users get a clean web interface for market data and portfolio tracking.
Its differentiator is institutional-grade data lineage — the granularity of historical trades is finer than typical aggregators, and the site publishes methodology documents and exchange quality ratings, making it well suited to integrators who require auditable data provenance. Compared with CoinMarketCap and CoinGecko, the retail experience is somewhat thinner, but the API depth and compliance posture are stronger.
Limitations and caveats: advanced historical data and high-frequency APIs sit behind paid plans, and the free tier has notable rate and field restrictions; the rating system is the site's own algorithmic output based on a published methodology that is revised across versions, so it should not be used as a sole decision input; all data and ratings on the site are research aids and do not constitute investment advice.